Capital I. 2015 Ltd F2 serves as Executive at TCR2 THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Capital I. 2015 Ltd F2 has executed 12 insider transactions totaling $3.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 11, 2019 involved selling 4,153 shares valued at $73.3K.
Capital I. 2015 Ltd F2 currently holds 1,299,876 shares of TCR2 THERAPEUTICS INC. (TCRR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital I. 2015 Ltd F2 has been a net seller of TCRR stock. They have purchased $0 and sold $3.6M worth of shares.
Capital I. 2015 Ltd F2's most recent insider trade was on Dec 11, 2019, when they sold 4,153 shares at $17.65 per share.
Get notified when new Form 4 filings are submitted
| $17.65 |
| Discretionary |
| Dec 11, 2019 | TCRR | $24.4K | Sale | 1,381 | $17.65 | Discretionary |
| Dec 11, 2019 | TCRR | $20.4K | Sale | 1,155 | $17.65 | Discretionary |
| Dec 10, 2019 | TCRR | $537.0K | Sale | 30,475 | $17.62 | Discretionary |
| Dec 10, 2019 | TCRR | $136.4K | Sale | 7,741 | $17.62 | Discretionary |
| Dec 10, 2019 | TCRR | $178.6K | Sale | 10,135 | $17.62 | Discretionary |
| Dec 10, 2019 | TCRR | $149.4K | Sale | 8,479 | $17.62 | Discretionary |
| Dec 9, 2019 | TCRR | $1.3M | Sale | 75,067 | $17.65 | Discretionary |
| Dec 9, 2019 | TCRR | $336.6K | Sale | 19,070 | $17.65 | Discretionary |
| Dec 9, 2019 | TCRR | $440.6K | Sale | 24,966 | $17.65 | Discretionary |
| Dec 9, 2019 | TCRR | $368.6K | Sale | 20,886 | $17.65 | Discretionary |